USEUROPEAFRICAASIA 中文双语Français
Home / Life

Extra time for Topsun, Bayer

By Jin Jing | China Daily | Updated: 2008-03-05 07:27

SHANGHAI: Topsun Science and Technology, the nation's leading privately owned pharmaceutical firm, will extend the time limit on a deal to sell its over-the-counter cough and cold business to Bayer.

The German firm will buy the Topsun subsidiary for 1.264 billion yuan - the biggest sum paid by a foreign company for a domestic drug maker.

Topsun signed a supplementary deal with Bayer on Feb 29 to extend the previous agreement to June 30, it told the Shanghai Stock Exchange in a statement. The terms remain the same.

Extra time for Topsun, Bayer

Today's Top News

Editor's picks

Most Viewed

Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US